Home Email Print This Page Home Email Print This Page Home Email Print This Page Email Home Print This Page


Imaging, segmentation, guidance and dosimetry for prostate brachytherapy

With graduate students Xu Wen (co-supervised with P.D. Lawrence),  Sara Badiei,  Diego Pranantha (co-supervised with R. Rohling), and  Nick Chng (co-supervised by Prof. Ingrid Spadinger who is the main supervisor). In collaboration with Dr. James Morris,  Dr. I. Spadinger from the British Columbia Cancer Agency. Funded by NSERC, NSERC/CIHR CHRP program and by NIH.
Brachytherapy is a widely used treatment for localized prostate cancer and it consists of the ultrasound-guided trans-perineal insertion of radioactive sources or "seeds" into the prostate to kill cancerous tissue. The insertion is performed by a radiation oncologist who uses a guiding template to insert needles into the prostate and place the seeds. Typically 25 to 35 needles are inserted with 80 to 130 seeds, according to a plan designed by a medical physicist with the goal of delivering sufficient radiation to kill the cancerous tissue while sparing the urethra and rectum.

Our goals are:

© 2001-2006 Tim Salcudean - last  updated November 2006